Abstract
In recent years, in vitro studies, including our own, have shown that re-expression of tumour suppressive microRNAs can alter malignant pleural mesothelioma (MPM) cell line growth, and that dysregulation of microRNAs might contribute to the intrinsic resistance towards the standard therapeutic regimen of platinum/pemetrexed. Since our screening for predictive biomarkers has revealed several candidates, we have recently decided to expand our studies from the three previously analysed microRNAs to a systematic evaluation of a larger number of predictive and prognostic biomarker candidates.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.